11β-Hydroxysteroid-dehydrogenase isoforms:: tissue distribution and implications for clinical medicine

被引:30
作者
Diederich, S [1 ]
Quinkler, M [1 ]
Burkhardt, P [1 ]
Grossmann, C [1 ]
Bähr, V [1 ]
Oelkers, W [1 ]
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Endocrinol, D-1000 Berlin, Germany
关键词
11; beta-hydroxysteroid-dehydrogenase; review; tissue distribution;
D O I
10.1046/j.1365-2362.2000.0300s3021.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11 beta -hydroxylation is essential for glucocorticoid and mineralocorticoid activity of a steroid. The enzyme catalyzing this reaction is termed 11 beta -hydroxysteroid-dehydrogenase (11 beta -HSD). Two isoenzymes of 11 beta -HSD have been characterized in human tissues. Whereas 11 beta -HSD-I works mainly as a reductase, 11 beta -HSD-II only functions as an oxidizing (inactivating) enzyme for physiological glucocorticoids. Thus, the tissue distribution of both enzymes plays a crucial role for the specific glucocorticoid status of an organ. This review summarizes our knowledge of tissue distribution of both 11 beta -HSD isoenzymes, their physiological function and pathophysiological role in certain clinical abnormalities, and their relevance to the metabolism of synthetic glucocorticoid and mineralocorticoid compounds.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 52 条
  • [31] IMPAIRED RENAL 11-BETA-OXIDATION OF 9-ALPHA-FLUOROCORTISOL - AN EXPLANATION FOR ITS MINERALOCORTICOID POTENCY
    OELKERS, W
    BUCHEN, S
    DIEDERICH, S
    KRAIN, J
    MUHME, S
    SCHONESHOFER, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) : 928 - 932
  • [32] PASQUALINI JR, 1970, J STEROID BIOCHEM, V1, P209
  • [33] A NEW DEFECT IN THE PERIPHERAL CONVERSION OF CORTISONE TO CORTISOL
    PHILLIPOU, G
    HIGGINS, BA
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 22 (03) : 435 - 436
  • [34] Apparent cortisone reductase deficiency: A unique form of hypercortisolism
    Phillipov, G
    Palermo, M
    Shackleton, CHL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) : 3855 - 3860
  • [35] Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues
    Ricketts, ML
    Verhaeg, JM
    Bujalska, I
    Howie, AJ
    Rainey, WE
    Stewart, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) : 1325 - 1335
  • [36] HYPERANDROGENISM IN POLYCYSTIC-OVARY-SYNDROME - EVIDENCE OF DYSREGULATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    RODIN, A
    THAKKAR, H
    TAYLOR, N
    CLAYTON, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (07) : 460 - 465
  • [37] Variation in placental type 2 11 beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight
    Rogerson, FM
    Kayes, KM
    White, PC
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 128 (1-2) : 103 - 109
  • [38] Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension
    Seckl, JR
    Benediktsson, R
    Lindsay, RS
    Brown, RW
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (5-6) : 447 - 455
  • [39] The 11 beta-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - Medical and physiological aspects of the 11 beta-hydroxysteroid dehydrogenase system
    Seckl, JR
    Chapman, KE
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (02): : 361 - 364
  • [40] Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: Evidence for nuclear localization
    Shimojo, M
    Ricketts, ML
    Petrelli, MD
    Moradi, P
    Johnson, GD
    Bradwell, AR
    Hewison, M
    Howie, AJ
    Stewart, PM
    [J]. ENDOCRINOLOGY, 1997, 138 (03) : 1305 - 1311